Latest Regulatory Approvals News

Neurizon Therapeutics has locked in a significant R&D tax incentive advance covering overseas and domestic development costs for its lead ALS drug candidate NUZ-001, accelerating its clinical progress with a $5.6 million rebate expected in 2025.

Neurizon Therapeutics has raised $5 million through an institutional placement to advance its lead ALS drug candidate NUZ-001 into a pivotal clinical trial, pending FDA clearance. The capital injection also supports manufacturing and pre-clinical development efforts.

Argent Minerals has reported outstanding high-grade silver and polymetallic mineralisation from diamond drillhole AKDD208 at its Kempfield Project, significantly enhancing the deposit’s resource potential.

OncoSil Medical’s PANCOSIL Phase 1-2 study reveals promising safety and feasibility for a novel CT-guided pancreatic cancer therapy, with survival outcomes exceeding historical benchmarks.

Imricor Medical Systems has successfully completed a comprehensive Human Factors study for all its devices under FDA review, marking a critical milestone towards U.S. market entry. The extensive 7-month study involved 46 healthcare professionals and tested nine products, underscoring Imricor’s growing momentum in electrophysiology innovation.

Dundee Precious Metals Inc. has completed its acquisition of Adriatic Metals Plc through a UK scheme of arrangement, gaining control of the Vareš Silver Operation. The deal, valued at approximately USD 1.3 billion, offers Adriatic shareholders a mix of cash and new DPM shares, underpinned by a detailed technical valuation.

Battery Age Minerals Limited has launched an offer of up to 29 million quoted options following a $3 million placement, aiming to support exploration projects in Austria and Argentina while managing shareholder dilution.

Buru Energy has secured environmental approval for its 2026 Rafael resource appraisal drilling campaign, a crucial step toward final investment and first cashflows by 2028.

Memphasys has upgraded its contract with ITL to A$390,000 and expanded its territory to include Turkey, marking its first contracted revenues in the EU ahead of expected CE Mark approval.

Critical Resources Limited has delineated a significant gold-antimony corridor at its Amoco Project in NSW, setting the stage for its maiden drilling campaign scheduled for early October 2025.

Brockman Mining reported a HK$34.6 million loss for FY2025 driven by exploration costs, while progressing key studies and approvals for its flagship Marillana iron ore project in Western Australia. The Group faces liquidity pressures but has secured shareholder loans to support ongoing development.

The XRG Consortium has withdrawn its indicative proposal to acquire Santos Limited, highlighting unresolved regulatory and risk allocation issues. Santos remains confident in its growth strategy, driven by key projects set to boost production and shareholder returns.